A randomized, open-label, two-way crossover clinical trial to evaluate the food effect on pharmacokinetics and safety of DHP107 in patients with advanced solid tumors: the FEEL study.
Saved in:
| Title: | A randomized, open-label, two-way crossover clinical trial to evaluate the food effect on pharmacokinetics and safety of DHP107 in patients with advanced solid tumors: the FEEL study. |
|---|---|
| Authors: | Hitre E; Department of Chemotherapy, National Institute of Oncology, Budapest, Hungary. hitre.erika@oncol.hu., Láng I; Clinexpert-Research, Budapest, Hungary., Páll D; Department of Medical Clinical Pharmacology, University of Debrecen, Debrecen, Hungary. |
| Source: | Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2026 May 30; Vol. 96 (1). Date of Electronic Publication: 2026 May 30. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase I; Multicenter Study |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
